The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic determinants of patterns of failure in metachronous oligometastatic castration-sensitive prostate cancer.
 
Philip Sutera
Employment - Catalent (I)
Stock and Other Ownership Interests - Catalent (I); Merck; Pfizer
 
Kim Van der Eecken
No Relationships to Disclose
 
Amol Shetty
No Relationships to Disclose
 
Yang Song
No Relationships to Disclose
 
Theresa Hodges
No Relationships to Disclose
 
Sofie Verbeke
No Relationships to Disclose
 
Jo Van Dorpe
No Relationships to Disclose
 
Valerie Fonteyne
Travel, Accommodations, Expenses - Ipsen
 
Bram De Laere
No Relationships to Disclose
 
Mark V. Mishra
Employment - Orthofix (I)
Stock and Other Ownership Interests - Adverum
 
Zaker Hamid Rana
No Relationships to Disclose
 
Jason K. Molitoris
No Relationships to Disclose
 
Matthew J. Ferris
No Relationships to Disclose
 
Nicholas J Roberts
No Relationships to Disclose
 
Daniel Y. Song
No Relationships to Disclose
 
Theodore L. DeWeese
Stock and Other Ownership Interests - Digital Harmonic
Patents, Royalties, Other Intellectual Property - patent pending on computer algorithm in radiation therapy planning
 
Kenneth J. Pienta
Leadership - CUE Biopharma; Keystone Biopharma
Stock and Other Ownership Interests - CUE Biopharma; Keystone Biopharma; Medsyn Biopharma; Oncopia Therapeutics
Consulting or Advisory Role - Akrevia Therapeutics; CUE Biopharma; GloriousMed Technology
Research Funding - Progenics
Travel, Accommodations, Expenses - CUE Biopharma
 
Matthew Deek
No Relationships to Disclose
 
Piet Ost
Consulting or Advisory Role - Astellas Pharma; Bayer; Curium Pharma; Janssen-Cilag; Novartis; Telix Pharmaceuticals
Research Funding - Bayer (Inst); Varian Medical Systems (Inst)
Travel, Accommodations, Expenses - Ferring
 
Phuoc T. Tran
Honoraria - Reflexion Medical
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Health; Bayer Health; Dendreon; GenomeDx; Janssen; Myovant Sciences; Noxopharm; Reflexion Medical; Reflexion Medical; Regeneron
Research Funding - Astellas Pharma (Inst); Bayer Health (Inst); Reflexion Medical (Inst)
Patents, Royalties, Other Intellectual Property - Compounds and Methods of Use in Ablative Radiotherapy. Patent filed 3/9/2012. PCT/US2012/028475. PCT/WO/2012/122471.
Travel, Accommodations, Expenses - Reflexion Medical